DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2025. Despite the robust ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Connacht team named to play Montauban in the European Challenge Cup. Kick Off tomorrow night in Dexcom Stadium is 8 pm.
While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
All four Irish provinces round off their Champions Cup and EPCR Challenge Cup pool stage campaigns this week. Here's ...
Barchart on MSN
DexCom's Q4 2025 earnings: What to expect
San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...
Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...
(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...
Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data and powerful ...
Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback